Letter: Congenital abnormalities and first-trimester exposure to progestagen/oestrogen.

J J Nora; A H Nora; A G Perinchief; J W Ingram; A K Fountain; M J Peterson

doi:10.1016/s0140-6736(76)91455-0

PubMed · 55633

Letter: Congenital abnormalities and first-trimester exposure to progestagen/oestrogen.

J J Nora·A H Nora·A G Perinchief·J W Ingram·A K Fountain·M J Peterson

View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Abnormalities, Drug-Induced Abnormalities, Multiple Estradiol Congeners Female Fetus Humans Infant, Newborn Maternal-Fetal Exchange Pregnancy Pregnancy Trimester, First Progesterone Congeners Prospective Studies Journal Article Research Support, U.S. Gov't, P.H.S.

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

J J Nora, A H Nora, A G Perinchief, J W Ingram, A K Fountain, M J Peterson. 1976-02-07. Letter: Congenital abnormalities and first-trimester exposure to progestagen/oestrogen.. https://doi.org/10.1016/s0140-6736(76)91455-0

Cite the original work for its findings. Save a collection to share your selection of sources.

Letter: Congenital abnormalities and first-trimester exposure to progestagen/oestrogen.

Abstract

Explore related subjects

Keep this discovery

Related citations

[Values and risks of pregnancy-protecting progesterones].

Safe use of drugs: how can it be achieved?

CDC study: no evidence for teratogenicity of Bendectin.